Elizabeth Ayres Fragoso Dobbin
Overview
Explore the profile of Elizabeth Ayres Fragoso Dobbin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
17
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Alcantara A, Pastana L, Albarello Gellen L, Vieira G, Dobbin E, Silva T, et al.
J Pers Med
. 2022 Dec;
12(12).
PMID: 36556273
The mucin (MUC) family includes several genes aberrantly expressed in multiple carcinomas and mediates diverse pathways essentials for oncogenesis, in both solid and hematological malignancies. Acute Lymphoblastic Leukemia (ALL) can...
2.
Bernardes J, Fernandes M, Rodrigues J, Vinagre L, Pastana L, Dobbin E, et al.
Genes (Basel)
. 2022 Apr;
13(4).
PMID: 35456428
Background: Prostate cancer represents 3.8% of cancer deaths worldwide. For most prostate cancer cells to grow, androgens need to bind to a cellular protein called the androgen receptor (AR). This...
3.
Cohen-Paes A, Carvalho D, Pastana L, Dobbin E, Moreira F, Piedade de Souza T, et al.
Genes (Basel)
. 2022 Mar;
13(3).
PMID: 35328053
Genetic variations in have been associated with different pathologies in global literature, but there are no data regarding this gene in Native American populations. The Amazonian Native American populations have...
4.
Fernandes M, Rodrigues J, Dobbin E, Pastana L, da Costa D, Barra W, et al.
Cancer Chemother Pharmacol
. 2021 Jul;
88(5):837-844.
PMID: 34331561
Purpose: Fluoropyrimidines are one of the most used drug class to treat cancer patients, although they show high levels of associated toxicity. This study analyzed 33 polymorphisms in 17 pharmacogenes...
5.
Dobbin E, Medeiros J, Costa M, Rodrigues J, Guerreiro J, Kroll J, et al.
Genes (Basel)
. 2021 Jan;
12(2).
PMID: 33499154
Estimates show that 5-10% of breast cancer cases are hereditary, caused by genetic variants in autosomal dominant genes; of these, 16% are due to germline mutations in the and genes....